Business Description

Description
Gene Biotherapeutics Inc is a clinical stage biotechnology company focused on pre-clinical, clinical, and commercialization of angiogenic gene therapy biotherapeutics for strategic niche markets primarily for the treatment of cardiovascular disease. The company's lead product candidate Generx is an angiogenic gene therapy product candidate designed for medical revascularization for the potential treatment of patients with myocardial ischemia and refractory angina due to advanced coronary artery disease.

Financial Strength

Name Current Vs Industry Vs History

Growth Rank

Name Current Vs Industry Vs History

Momentum Rank

Name Current Vs Industry Vs History

Liquidity Ratio

Name Current Vs Industry Vs History

Dividend & Buy Back

Name Current Vs Industry Vs History

Profitability Rank

Name Current Vs Industry Vs History

GF Value Rank

Name Current Vs Industry Vs History

Financials

CRXM's 30-Y Financials
Income Statement Breakdown FY
No Enough Data
Balance Sheet Breakdown
No Enough Data
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Gurus Latest Trades with OTCPK:CRXM

No Available Data

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

Gene Biotherapeutics Inc Executives

Details

GF Value

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil $)
EPS (TTM) ($) -0.038
Beta -3.13
Volatility % 0
14-Day RSI 0
14-Day ATR ($) 0
20-Day SMA ($) 0.0001
12-1 Month Momentum % 0
52-Week Range ($) 0.0001 - 0.0001
Shares Outstanding (Mil) 64.93

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 0
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

Gene Biotherapeutics Inc Filings

Filing Date Document Date Form
No Filing Data

Gene Biotherapeutics Inc Stock Events

Financials Calendars
Event Date Price($)
No Event Data

Gene Biotherapeutics Inc Frequently Asked Questions

What is Gene Biotherapeutics Inc(CRXM)'s stock price today?
The current price of CRXM is $0.00. The 52 week high of CRXM is $0.00 and 52 week low is $0.00.
When is next earnings date of Gene Biotherapeutics Inc(CRXM)?
The next earnings date of Gene Biotherapeutics Inc(CRXM) is .
Does Gene Biotherapeutics Inc(CRXM) pay dividends? If so, how much?
Gene Biotherapeutics Inc(CRXM) does not pay dividend.

Press Release

Subject Date
No Press Release

Headlines

See More
  • 1
No news.
  • 1